LBA-5 ANCHOR CRC: a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer
Axel Grothey, Josep Tabernero, Julien Taı̈eb, Rona Yaeger, Takayuki Yoshino, Evaristo Maiello, E. Elez Fernandez, A. Ruiz Casado, Paul J. Ross, Thierry André, Takeshi Kato, J.C. Ruffinelli, Janet Graham, Marc Van den Eynde, Ruth Vera, Baptiste Niyibizi Jean, E. Carriere Roussel, C. Cahuzac, Zahida Issiakhem, Jean-Claude Vedovato, Eric Van Cutsem
Topics & Concepts
MedicineCetuximabColorectal cancerOncologyInternal medicineMutantPhases of clinical researchCancer researchCancerClinical trialGeneticsBiologyGeneColorectal Cancer Treatments and StudiesMelanoma and MAPK PathwaysCancer Treatment and Pharmacology